US Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI)

Clinical trial NCT04125290 · TERMINATED

Trial details

NCT number: NCT04125290
Sponsor: AstraZeneca
Status: TERMINATED
Study type: OBSERVATIONAL

Hairy Cell Leukemia

Start date: 2019-12-09
Primary completion: 2021-06-21
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.